The 2019 Cancer Statistics report by the American Cancer Society estimates that 1,762,450 new cancer cases and 606,880 cancer deaths will occur in the United States. Over the past decade, cancer incidence rates in women remained stable, while men saw a 2% annual decline. Cancer death rates declined annually by 1.4% and 1.8% for men and women, respectively, leading to a 27% overall reduction since 1991, preventing approximately 2.6 million cancer deaths. Despite narrowing racial gaps in cancer mortality, socioeconomic disparities are widening, with the poorest counties experiencing higher mortality rates for preventable cancers like cervical and lung cancer. For example, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers compared to affluent counties. Cancer survival has improved significantly, with 5-year relative survival rates for all cancers combined at 67% for whites and 62% for blacks in 2008–2014. Prostate cancer survival is particularly high, at 98%, while survival for pancreatic, liver, and esophageal cancers remains low. Survival improvements are attributed to better detection, treatment, and screening practices, especially for cancers like breast, prostate, and colorectal. However, lung and pancreatic cancers continue to have poor survival rates due to late diagnosis. Cancer disparities by race and ethnicity are significant, with non-Hispanic blacks having higher cancer mortality rates than whites. Geographic variations in cancer occurrence are also notable, with lung cancer incidence rates varying widely by state, reflecting differences in smoking prevalence. Children and adolescents account for a significant portion of cancer cases, with leukemia being the most common childhood cancer. Despite progress in reducing cancer mortality, disparities persist, particularly among disadvantaged populations. The report highlights the importance of addressing socioeconomic and racial disparities in cancer outcomes through improved access to care, early detection, and prevention strategies. It also emphasizes the need for continued research and policy efforts to reduce cancer burden and improve survival rates.The 2019 Cancer Statistics report by the American Cancer Society estimates that 1,762,450 new cancer cases and 606,880 cancer deaths will occur in the United States. Over the past decade, cancer incidence rates in women remained stable, while men saw a 2% annual decline. Cancer death rates declined annually by 1.4% and 1.8% for men and women, respectively, leading to a 27% overall reduction since 1991, preventing approximately 2.6 million cancer deaths. Despite narrowing racial gaps in cancer mortality, socioeconomic disparities are widening, with the poorest counties experiencing higher mortality rates for preventable cancers like cervical and lung cancer. For example, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers compared to affluent counties. Cancer survival has improved significantly, with 5-year relative survival rates for all cancers combined at 67% for whites and 62% for blacks in 2008–2014. Prostate cancer survival is particularly high, at 98%, while survival for pancreatic, liver, and esophageal cancers remains low. Survival improvements are attributed to better detection, treatment, and screening practices, especially for cancers like breast, prostate, and colorectal. However, lung and pancreatic cancers continue to have poor survival rates due to late diagnosis. Cancer disparities by race and ethnicity are significant, with non-Hispanic blacks having higher cancer mortality rates than whites. Geographic variations in cancer occurrence are also notable, with lung cancer incidence rates varying widely by state, reflecting differences in smoking prevalence. Children and adolescents account for a significant portion of cancer cases, with leukemia being the most common childhood cancer. Despite progress in reducing cancer mortality, disparities persist, particularly among disadvantaged populations. The report highlights the importance of addressing socioeconomic and racial disparities in cancer outcomes through improved access to care, early detection, and prevention strategies. It also emphasizes the need for continued research and policy efforts to reduce cancer burden and improve survival rates.